SSTC M.Pharm FAQs
Ques. What is the focus of M.Pharm (Pharmaceutics) at SSTC Bhilai, and how is it different from other M.Pharm specialisations?
Ans. M.Pharm (Pharmaceutics) at SSTC Bhilai focuses on the science and technology of drug formulation - including tablet, capsule, liquid, and novel drug delivery systems such as nanoparticles, liposomes, and transdermal patches. It also covers biopharmaceutics (how drugs are absorbed and distributed in the body) and pharmacokinetics. This specialisation is more industry-oriented compared to Pharmaceutical Chemistry (which focuses on drug synthesis) or Pharmacology (which focuses on drug action mechanisms). Pharmaceutics graduates are in high demand in pharmaceutical manufacturing companies.
Ques. Is GPAT mandatory for M.Pharm (Pharmaceutics) admission at SSTC Bhilai, and what is the benefit of qualifying GPAT?
Ans. GPAT is not mandatory for admission to M.Pharm (Pharmaceutics) at SSTC Bhilai. The college accepts both GPAT-qualified and direct merit-based applicants. However, qualifying GPAT provides two major advantages: first, GPAT-qualified candidates get preference in the merit list; second, they are eligible for the AICTE scholarship of Rs. 12,400 per month for the entire 2-year duration. Over 24 months, this scholarship amounts to Rs. 2,97,600, which is significantly more than the total course fee of Rs. 1,93,000.
Ques. What is the affiliation and recognition status of M.Pharm (Pharmaceutics) at SSTC Bhilai?
Ans. The M.Pharm (Pharmaceutics) programme at SSTC Bhilai is affiliated to Chhattisgarh Swami Vivekanand Technical University (CSVTU), Bhilai, and is approved by AICTE and the Pharmacy Council of India (PCI). The degree is nationally recognised and graduates are eligible for employment in pharmaceutical industries, government positions, and academic roles. The PCI recognition ensures that the programme meets the national standards for pharmacy education in India.
Ques. What are the career opportunities after M.Pharm (Pharmaceutics) from SSTC Bhilai?
Ans. M.Pharm (Pharmaceutics) graduates can pursue careers as Formulation Scientists, Drug Delivery Specialists, Quality Assurance/Quality Control Officers, Regulatory Affairs Executives, Production Managers, and Research Scientists in pharmaceutical companies. They can also work in CROs, government drug testing laboratories, and academic institutions. The pharmaceutical industry in India is one of the largest in the world, and there is consistent demand for M.Pharm (Pharmaceutics) graduates. Starting salaries typically range from Rs. 3 to 6 lakhs per annum.
Ques. Can I pursue a Ph.D. after completing M.Pharm (Pharmaceutics) from SSTC Bhilai?
Ans. Yes, M.Pharm (Pharmaceutics) graduates from SSTC Bhilai are eligible to apply for Ph.D. programmes in Pharmaceutics, Pharmaceutical Sciences, or related fields at universities across India. CSVTU Bhilai also offers Ph.D. programmes in pharmaceutical sciences. Additionally, graduates can apply for Ph.D. positions at central universities, IITs, NITs, and national research institutes. A strong academic record and research experience during M.Pharm significantly improves the chances of securing a Ph.D. admission.
Ques. How many seats are available for M.Pharm (Pharmaceutics) at SSTC Bhilai, and when should I apply?
Ans. SSTC Bhilai has 15 seats for M.Pharm (Pharmaceutics). Applications are typically accepted from June to July each year, with the batch commencing in August. Since the number of seats is limited, candidates are advised to apply early and ensure all documents are in order. GPAT-qualified candidates should apply with their GPAT scorecard to avail of both admission preference and the AICTE scholarship. Candidates without GPAT scores can also apply based on their B.Pharm percentage.


![Shri Shankaracharya Group of Institutions - [SSGI]](https://image-static.collegedunia.com/public/college_data/images/logos/150312918814969888471496908879sstclogoa.jpg?h=71.7&w=71.7&mode=stretch)






.png?h=78&w=78&mode=stretch)


















.png?h=72&w=72&mode=stretch)





















Comments